ARCHIVES

ODAC Recommends Fludarabine Approval for Refractory CLL

This article is from The Cancer Letter archive.

Vol. 16 No. 36 | September 21, 1990

Download PDF Visit The Full Archive

Related Articles

NCI R01 Payline Falls To 12th Percentile In Fifth Year Of No-Growth Budgets.

March 7, 2008

National Academy Of Sciences To form Cancer Policy Board At NCI’s Request

August 16, 1996

Triple-Negative Breast Cancer Equally Aggressive in Whites

February 25, 2011

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

December 5, 2014

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002

DCE Board Approves Support Contract Recompetition

July 6, 1990